With approval of the Guideline 4000 LP+ neuromodulation targeting system for sale in Canada, FHC technology will now be available to Canadian neurosurgeons.

FHC’s line of clinical products for recording and stimulating are powerful, user-friendly, and streamlined systems.  The microTargeting™ Guideline 4000 LP+™ offers neurosurgical teams offers the most powerful targeting system on the market in a streamlined, affordable package.  Optimized for clinical use (user-specifiable channel count, streamlined setup, rugged design), the LP+ continues to support high-powered research (fully adjustable digital filters, wideband recording capabilities, straightforward data export and analysis).

Learn more about the Guideline 4000 LP+ by visiting our product page.